Pharmacogenetic Supported Prescribing in Kids

NARecruitingINTERVENTIONAL
Enrollment

6,000

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Mental Health Impairment
Interventions
DIAGNOSTIC_TEST

Pharmacogenetic Testing

Participants will donate a 2ml (teaspoon) sample of saliva. DNA extracted from the saliva sample will be used for genotyping. Genotyping results will be translated into an interpretative clinical report using evidence-based software (Sequence2Script) developed by our group and delivered to the treating physician for use in their clinical decision-making. The report will contain genotyping results, predicted phenotype, and evidence-based drug selection and dosing recommendations relevant to the child's current and future care

Trial Locations (1)

T2N 4N1

RECRUITING

University of Calgary, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER